Free Trial

Jackson Hole Capital Partners LLC Acquires New Holdings in Grail, Inc. (NASDAQ:GRAL)

Grail logo with Medical background
Remove Ads

Jackson Hole Capital Partners LLC bought a new stake in Grail, Inc. (NASDAQ:GRAL - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 33,000 shares of the company's stock, valued at approximately $589,000. Jackson Hole Capital Partners LLC owned approximately 0.10% of Grail as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also modified their holdings of the company. FNY Investment Advisers LLC acquired a new stake in Grail in the fourth quarter valued at approximately $26,000. Lindbrook Capital LLC purchased a new position in shares of Grail in the fourth quarter valued at $28,000. New York State Common Retirement Fund acquired a new stake in Grail during the 4th quarter valued at $59,000. Wilmington Savings Fund Society FSB purchased a new stake in Grail during the 4th quarter worth $64,000. Finally, PNC Financial Services Group Inc. acquired a new position in Grail in the 4th quarter worth $86,000.

Grail Trading Down 12.7 %

NASDAQ GRAL traded down $3.93 during trading hours on Thursday, reaching $26.92. 1,577,733 shares of the company traded hands, compared to its average volume of 1,226,846. Grail, Inc. has a 12 month low of $12.33 and a 12 month high of $63.99. The company has a 50 day moving average of $31.42 and a two-hundred day moving average of $21.15.

Grail (NASDAQ:GRAL - Get Free Report) last issued its quarterly earnings results on Thursday, February 20th. The company reported ($1.86) EPS for the quarter, topping the consensus estimate of ($4.41) by $2.55. The company had revenue of $38.25 million for the quarter, compared to the consensus estimate of $35.33 million. As a group, research analysts predict that Grail, Inc. will post -15.15 earnings per share for the current fiscal year.

Remove Ads

Insider Transactions at Grail

In other Grail news, President Joshua J. Ofman sold 2,109 shares of Grail stock in a transaction on Friday, March 7th. The shares were sold at an average price of $31.20, for a total value of $65,800.80. Following the completion of the transaction, the president now owns 559,673 shares of the company's stock, valued at $17,461,797.60. The trade was a 0.38 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Robert P. Ragusa sold 7,625 shares of the business's stock in a transaction on Friday, March 7th. The shares were sold at an average price of $31.21, for a total transaction of $237,976.25. Following the sale, the chief executive officer now owns 828,662 shares of the company's stock, valued at approximately $25,862,541.02. The trade was a 0.91 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 11,550 shares of company stock worth $360,436.

Wall Street Analysts Forecast Growth

GRAL has been the topic of a number of analyst reports. Morgan Stanley began coverage on Grail in a research report on Wednesday, November 27th. They set an "equal weight" rating and a $16.00 target price on the stock. Wolfe Research began coverage on Grail in a report on Friday, November 15th. They set a "peer perform" rating on the stock.

Get Our Latest Analysis on Grail

Grail Company Profile

(Free Report)

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.

Read More

Institutional Ownership by Quarter for Grail (NASDAQ:GRAL)

Should You Invest $1,000 in Grail Right Now?

Before you consider Grail, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grail wasn't on the list.

While Grail currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost
Quantum Stocks Are Heating Up Again — 7 to Watch Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads